JAMES LEE to Risk Assessment
This is a "connection" page, showing publications JAMES LEE has written about Risk Assessment.
Connection Strength
0.022
-
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2021 03; 109(3):705-715.
Score: 0.022